Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cameron Durrant currently holds 70,000 shares of KALOBIOS PHARMACEUTICALS INC (KBIOQ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cameron Durrant has been a net seller of KBIOQ stock. They have purchased $103.6K and sold $1.7M worth of shares.
Cameron Durrant's most recent insider trade was on Mar 2, 2022, when they purchased 40,000 shares at $2.34 per share.
Cameron Durrant serves as Executive at KALOBIOS PHARMACEUTICALS INC (KBIOQ). They have executed 20 insider transactions totaling $1.8M over their tenure at the company.
Cameron Durrant holds the position of Executive at KALOBIOS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Cameron Durrant has shown a selling trading pattern, with $103.6K in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cameron Durrant was on Jun 14, 2021, when they sold $1.0M worth of HGEN shares. This transaction involved 49,906 shares at $20.61 per share.
Cameron Durrant currently owns 70,000 shares of KALOBIOS PHARMACEUTICALS INC (KBIOQ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cameron Durrant's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cameron Durrant has 20 Form 4 filings on record as an insider at KALOBIOS PHARMACEUTICALS INC.
Set alerts for Cameron Durrant and 40,000+ other insiders.